News

FDA approves bevacizumab-bvzr for several cancers
The bevacizumab biosimilar is now approved for metastatic colorectal cancer, advanced non-squamous non–small cell lung cancer, recurrent...
The bevacizumab biosimilar is now approved for metastatic colorectal cancer, advanced non-squamous non–small cell lung cancer, recurrent...
Have you noticed that you and your staff are spending more time on prior authorization than in the past? Insurance companies are increasing the...
In women, these associations included salmonella infection, sepsis, and uveitis; in men, they included gangrene, encephalitis, and hidradenitis...
After implementation of the default order specifying no daily imaging during palliative radiation therapy, patients were 63% less likely to...
Clinical Challenges - July 2019